# A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma

> **NCT01881529** · — · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 29 (actual)

## Conditions studied

- Limited Scleroderma
- Diffuse Scleroderma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01881529
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2014-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01881529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01881529, "A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01881529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*